Contrast Agents in MRI Market: information by Types (Barium Based, Iodinated, Gadolinium Based, Micr

Page 1

Page 1 of 3

Contrast Agents in MRI Market Revenue Trends, Company Profiles, Revenue Share Analysis, 2021–2026 MRI contrast agents are used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). It is widely used in compounds for contrast enhancement are gadolinium-based. Furthermore, the company spends millions of dollars on R&D to find appropriate agents. For instance, GE Healthcare and Schering AG spend approximately 10%–15% of the total MRI contrast agent’s sales revenue on its research & development. Thus, any company can increase the profit margin on the products by decreasing the cost of bringing a drug to the market. The Major Players Covered in this Report: Unijules Life Sciences Ltd.(India), Spago Nanomedical AB(Sweden), Lantheus Medical Imaging, Inc.(U.S.) , J.B. Chemicals and Pharmaceuticals Limited(India), Guerbet LLC(France), GE Healthcare(U.S.), Daiichi Sankyo Company, Limited(Japan), Bracco Imaging S.p.A.( Italy), Bayer Healthcare AG(Germany), Jodas Expoim(India), Magnus Health(India) Global contrast agents in MRI market accounted for approximately USD 4,353.2 million in 2018 and is expected to grow at a CAGR of 4.0 % during the forecast period, 2019–2026. Get a Sample PDF Report: https://straitsresearch.com/report/Contrast-Agents-in-MRI-market/request-sample By Type: Barium Based, Iodinated, Gadolinium Based, Microbubble, Surgical Centers, Others By Application: Oncology, Cardiology, Neurology, Inflammations, Others Segmental Insights The global contrast agents for magnetic resonance imaging (MRI) market is segmented on the basis of type and application. Based on type, the market is segmented into barium-based contrast media, iodinated contrast media, gadolinium-based contrast media, and micro bubble contrast media. Iodinated contrast media valued USD 1,889.4 million in 2017 and is projected to dominate the market in the coming years. Barium-based contrast media segment is expected to grow at the highest CAGR of 4.3% during the forecast period 2018–2025. Barium-based contrast media is commonly used in the diagnostic examinations of the diseases related to stomach, esophagus, small intestine, large intestine, and pharynx. For the diagnostic tests of diseases related to the gastrointestinal tract, barium-based contrast media is administered rectally by enema.

sales@straitsresearch.com

+1 646 480 7505 (U.S.) || +44 208 068 9665 (U.K.)


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.